Pharmaceutical News

RSS

UC Riverside researchers discover way to halt cancer metastasis

A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

23 Feb 2018

Highly sensitive ELISA method for analysis of CET in plasma samples

This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.

23 Feb 2018

Carbon monoxide enhances efficacy of antibiotic against stomach infection

Carbon monoxide can improve the effectiveness of antibiotics, making bacteria more sensitive to antibiotic medication, according to a study led by Georgia State University.

22 Feb 2018

Alfa Laval UltraPure pumps meet the needs of most demanding pharmaceutical applications

Alfa Laval UltraPure pumps are specifically designed for the toughest, most demanding pharmaceutical applications. From high-value, high-risk productions, where every second counts, to reliability and repeatability process-driven productions - whatever your challenge is, there is an UltraPure solution to meet your needs.

From Alfa Laval Corporate AB 22 Feb 2018

Scientists reveal development of improved medicine to fight addiction

Drug addiction continues to plague vast numbers of people across the world, destroying and ending lives, while attempts to develop more effective pharmaceutical addiction treatments continue.

21 Feb 2018

Prophylactic use of haloperidol does not reduce delirium burden

Prophylactic use of the drug haloperidol does not help to prevent delirium in intensive care patients or improve their chances of survival. Therefore, there is no reason anymore to administer the drug as a preventive measure to reduce the burden of delirium.

21 Feb 2018

Researchers provide safety data for common antiparasitic drug used to treat Chagas disease

Benznidazole is one of the two existing antiparasitic drugs for Chagas' disease treatment. However, it is a poorly tolerated drug and its use to treat chronic disease raises safety concerns. Knowledge about its toxicity profile is scarce and mostly based on post-marketing observational studies.

20 Feb 2018

Vitamin D supplementation during pregnancy could protect against childhood obesity

Every parent wants to give their child the best start in life, but what if that consideration needed to happen before the baby was even born?

From BetterYou Ltd 20 Feb 2018

Stanford researchers explore how enzyme changes and becomes antibiotic-resistant

Enzymes are proteins that speed up or catalyze a reaction in living organisms. Bacteria can produce enzymes that make them resistant to antibiotics.

19 Feb 2018

Shot may help reduce risk of shingles

Anyone who has had chickenpox or the chickenpox vaccine is at risk for the painful skin condition herpes zoster, more commonly known as shingles. Both diseases are caused by the varicella-zoster virus, which stays in the body after chickenpox clears and may reactivate later in life.

18 Feb 2018

FDA approves first treatment to reduce risk of NSCLC progression

The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).

18 Feb 2018

High blood pressure drug may also help prevent onset of type 1 diabetes

A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida in Gainesville.

15 Feb 2018

Women using short-acting asthma relievers take longer to become pregnant, study shows

Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to international research led by the University of Adelaide.

15 Feb 2018

New guidelines offer recommendations for assessment, management of immunotherapy side effects

Immunotherapy with immune checkpoint inhibitors is the first of a new generation of immunotherapy treatments, revolutionizing treatment for many different types of cancer. By unleashing the body's immune system to attack cancer, these treatments can send even the most hard-to-treat cancers into lasting remission.

15 Feb 2018

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.

15 Feb 2018

New review explores whether oral nutraceuticals benefit skin appearance

A review of published research conducted by nutrition scientists at the British Nutrition Foundation reveals a very limited evidence base to support some of the ingredients used in popular, and often costly, orally consumed beauty supplements, that promise ‘youthful’, ‘firm’ and ‘glowing’ skin.

14 Feb 2018

Surgical infection in low-income nations linked to drug-resistant bacteria, research suggests

Patients having surgery in low-income countries are more likely to develop an infection than those in wealthier nations, which may be linked to drug-resistant bacteria, research led by the Universities of Birmingham, Edinburgh and Warwick suggests.

14 Feb 2018

A new antibiotic Malacidin from soil kills resistant bacteria

Researchers have come up with a new class of antibiotics from soil. This novel antibiotic, called malacidin, is hailed as the next big thing because of its ability to work against many of the multidrug-resistant bacterial strains.

14 Feb 2018

Light-activated cancer drugs without toxic side effects are closer to becoming reality

Future cancer drugs that are activated by light and don't cause the toxic side-effects of current chemotherapy treatments are closer to becoming a reality, thanks to new research made possible by the Monash Warwick Alliance, an intercontinental collaboration between the University of Warwick and Monash University.

13 Feb 2018

Study: Most children with sickle cell anemia not getting daily antibiotics to reduce the risk

One of the greatest health threats to children with sickle cell anemia is getting a dangerous bacterial infection - but most are not receiving a key medication to reduce the risk, a new study suggests.

13 Feb 2018

Pharmaceutical News

UC Riverside researchers discover way to halt cancer metastasis

Highly sensitive ELISA method for analysis of CET in plasma samples

Carbon monoxide enhances efficacy of antibiotic against stomach infection

Alfa Laval UltraPure pumps meet the needs of most demanding pharmaceutical applications

Scientists reveal development of improved medicine to fight addiction

Prophylactic use of haloperidol does not reduce delirium burden

Researchers provide safety data for common antiparasitic drug used to treat Chagas disease

Vitamin D supplementation during pregnancy could protect against childhood obesity

Stanford researchers explore how enzyme changes and becomes antibiotic-resistant

Shot may help reduce risk of shingles

FDA approves first treatment to reduce risk of NSCLC progression

High blood pressure drug may also help prevent onset of type 1 diabetes

Women using short-acting asthma relievers take longer to become pregnant, study shows

New guidelines offer recommendations for assessment, management of immunotherapy side effects

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

New review explores whether oral nutraceuticals benefit skin appearance

Surgical infection in low-income nations linked to drug-resistant bacteria, research suggests

A new antibiotic Malacidin from soil kills resistant bacteria

Light-activated cancer drugs without toxic side effects are closer to becoming reality

Study: Most children with sickle cell anemia not getting daily antibiotics to reduce the risk

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News